It is likely that patients with a lower platelet count had more severe portal hypertension and that the vascular derangements secondary to portal hypertension lead to the decreased expression of the receptors for proangiogenic factors like FGFR1, FGFR2, and VEGFR2. Here, KDR is linked to portal hypertension.